Pharmacological Management of Pulmonary Arterial Hypertension

Author(s): Beatrice Adams, PharmD, BCPS, Kevin T. Ferguson, PharmD, BCPS

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 1.00

Expires Dec 01, 2018

Topics: Pharmacology, Pulmonary

Population: Adult

Role: APRN

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Pulmonary hypertension (PH) is a complex disorder that was first described in a case report as “pulmonary vascular sclerosis” in 1891 by German internist Dr Ernst von Romberg. 1 Without treatment, it is a progressive, fatal disease that is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. According to the most recent evidence from a national French registry, the prevalence of pulmonary arterial hypertension (PAH) is about 15 cases per 1 million adult inhabitants with an incidence of 2.4 cases per 1 million adult inhabitants. 2 According to a registry that evaluates early and long-term PAH disease management, the prevalence of PAH in the United States is 12.4 cases per million and the incidence is 2.3 cases per million. 3 Unfortunately, not all cases of PAH are reported to the registries, so both the prevalence and incidence data are considered low estimates.

Objectives

  • Understand the classification of pulmonary arterial hypertension (PAH).
  • Identify the drugs used to treat pulmonary hypertension (PH).
  • Recognize adverse effects of drugs used to treat PH.

Continuing Education Disclosure Statement

Successful Completion

Learners must attend/view/read the entire activity and complete the associated evaluation to be awarded the contact hours or CERP. No partial credit will be awarded.

Disclosure

This activity has been reviewed by the Nurse Planner. It has been determined that the material presented here shows no bias. Approval of a continuing education activity does not imply endorsement by AACN or ANCC of any commercial products displayed or discussed in conjunction with the activity.

Accreditation

The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1.2 contact hours (50 min contact hour).

AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal. AACN recommends consulting with your state board of nursing or credentialing organization before submitting CE to fulfill continuing education requirements.